PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
CD22 1,591 Target Target Epidermal Growth Factor Receptor 24,772 1 0.00 -1.00 0.00 0.52
CD22 1,591 Target Disease Skin Disease 6,955 1 0.00 -1.00 0.00 0.56
CD22 1,591 Target Disease Seizure 44,685 1 0.00 -1.00 0.00 0.51
CD22 1,591 Target Target Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 1 0.00 -1.00 0.00 0.56
CD22 1,591 Target Disease Central Nervous System Diseases 715 1 0.00 -1.00 0.00 0.62
CD22 1,591 Target Target BLK 255 1 0.00 -1.00 0.00 0.64
CD22 1,591 Target Disease Miscarriages 3,138 1 0.00 -1.00 0.00 0.58
CD22 1,591 Target Disease Chills 3,046 1 0.00 -1.00 0.00 0.58
CD22 1,591 Target Disease Shigella Infection 244 1 0.00 -1.00 0.00 0.64
CD22 1,591 Target Disease Cervical Cancer 28,286 1 0.00 -1.00 0.00 0.52
CD22 1,591 Target Disease Fracture 111,575 1 0.00 -1.00 0.00 0.49
CD22 1,591 Target Disease Albuminuria 6,831 1 0.00 -1.00 0.00 0.56
CD22 1,591 Target Disease Non Insulin Dependent Diabetes Mellitus 6,686 1 0.00 -1.00 0.00 0.56
CD22 1,591 Target Disease Chronic Obstructive Pulmonary Disease 27,780 1 0.00 -1.00 0.00 0.52
CD22 1,591 Target Disease Skin Cancer 11,561 1 0.00 -1.00 0.00 0.54
CD22 1,591 Target Disease Hyperglycemia 28,168 1 0.00 -1.00 0.00 0.52
CD22 1,591 Target Disease Infectious Diseases 33,605 1 0.00 -1.00 0.00 0.51
CD22 1,591 Target Disease Kidney Diseases 4,651 1 0.00 -1.00 0.00 0.57
CD22 1,591 Target Disease Glaucoma 41,465 1 0.00 -1.00 0.00 0.51
CD22 1,591 Target Disease Scleritis 1,191 1 0.00 -1.00 0.00 0.61
CD22 1,591 Target Disease Shigellosis 1,819 1 0.00 -1.00 0.00 0.60
CD22 1,591 Target Disease Cryoglobulinemia 2,693 1 0.00 -1.00 0.00 0.58
CD22 1,591 Target Disease Basal Cell Carcinoma 7,953 1 0.00 -1.00 0.00 0.55
CD22 1,591 Target Target ETS1 539 1 0.00 -1.00 0.00 0.62
CD22 1,591 Target Target Endotoxin receptor 115 1 0.00 -1.00 0.01 0.65
CD22 1,591 Target Target A1AT 329 1 0.00 -1.00 0.00 0.63
CD22 1,591 Target Disease Renal Failure 73,993 1 0.00 -1.00 0.00 0.50
CD22 1,591 Target Disease Organ Transplantation 11,384 1 0.00 -1.00 0.00 0.54
CD22 1,591 Target Disease Respiratory Tract Infections 9,721 1 0.00 -1.00 0.00 0.55
CD22 1,591 Target Target BMX 185 1 0.00 -1.00 0.01 0.64
CD22 1,591 Target Disease Joint Pain 4,215 1 0.00 -1.00 0.00 0.57
CD22 1,591 Target Disease Xerostomia 3,054 1 0.00 -1.00 0.00 0.58
CD22 1,591 Target Target CD146 729 1 0.00 -1.00 0.00 0.62
CD22 1,591 Target Disease Keratitis 10,599 1 0.00 -1.00 0.00 0.54
CD22 1,591 Target Target CCL3 1,427 1 0.00 -1.00 0.00 0.60
CD22 1,591 Target Target C7 7,027 1 0.00 -1.00 0.00 0.56
CD22 1,591 Target Disease Ileus 9,091 1 0.00 -1.00 0.00 0.55
CD22 1,591 Target Disease Irritable Bowel Syndrome 8,230 1 0.00 -1.00 0.00 0.55
CD22 1,591 Target Drug Alemtuzumab (Campath)- FDA 32 1 0.00 -0.98 0.03 0.67
CD22 1,591 Target Target EGF 27,487 1 0.00 -1.00 0.00 0.52
CD22 1,591 Target Target AGP 2,006 1 0.00 -1.00 0.00 0.59
CD22 1,591 Target Disease Rheumatic Fever 6,356 1 0.00 -1.00 0.00 0.56
CD22 1,591 Target Disease Rare Diseases 2,212 1 0.00 -1.00 0.00 0.59
CD22 1,591 Target Disease Syphilis 20,217 1 0.00 -1.00 0.00 0.53
CD22 1,591 Target Disease Hemorrhoids 2,290 1 0.00 -1.00 0.00 0.59
CD22 1,591 Target Disease Sinusitis 12,330 1 0.00 -1.00 0.00 0.54
CD22 1,591 Target Disease Brain Tumors 16,749 1 0.00 -1.00 0.00 0.53
CD22 1,591 Target Disease Muscle Weakness 9,178 1 0.00 -1.00 0.00 0.55
CD22 1,591 Target Disease Bacterial Infections 14,248 1 0.00 -1.00 0.00 0.54
CD22 1,591 Target Disease Proteinuria 28,803 1 0.00 -1.00 0.00 0.52